There were 23 press releases posted in the last 24 hours and 166,036 in the last 365 days.

Global Bipolar Disorder Industry

Bipolar Disorder market worldwide is projected to grow by US$848. 8 Million, driven by a compounded growth of 2. 3%. Mood Stabilizers, one of the segments analyzed and sized in this study, displays the potential to grow at over 1.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Bipolar Disorder Industry" - https://www.reportlinker.com/p05817972/?utm_source=GNW
6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$608.5 Million by the year 2025, Mood Stabilizers will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 1.9% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$34 Million to the region’s size and clout in the next 5 to 6 years. Over US$24.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Mood Stabilizers will reach a market size of US$28.3 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.6% over the next couple of years and add approximately US$231.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, AbbVie, Inc.; Allergan PLC; AstraZeneca PLC; Eli Lilly and Company; GlaxoSmithKline PLC; Janssen Pharmaceuticals; Novartis International AG; Otsuka Pharmaceutical Co., Ltd.; Pfizer, Inc.


Read the full report: https://www.reportlinker.com/p05817972/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Bipolar Disorder Competitor Market Share Scenario Worldwide
(in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Bipolar Disorder Global Market Estimates and Forecasts
in US$ Million by Region/Country: 2018-2025
Table 2: Bipolar Disorder Global Retrospective Market Scenario
in US$ Million by Region/Country: 2009-2017
Table 3: Bipolar Disorder Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Mood Stabilizers (Drug Class) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Mood Stabilizers (Drug Class) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 6: Mood Stabilizers (Drug Class) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Anticonvulsants (Drug Class) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Anticonvulsants (Drug Class) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 9: Anticonvulsants (Drug Class) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Antipsychotic Drugs (Drug Class) Geographic Market
Spread Worldwide in US$ Million: 2018 to 2025
Table 11: Antipsychotic Drugs (Drug Class) Region Wise
Breakdown of Global Historic Demand in US$ Million: 2009 to
2017
Table 12: Antipsychotic Drugs (Drug Class) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 13: Antidepressant Drugs (Drug Class) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2018
to 2025
Table 14: Antidepressant Drugs (Drug Class) Market Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 15: Antidepressant Drugs (Drug Class) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 16: Anti-anxiety Drugs (Drug Class) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Anti-anxiety Drugs (Drug Class) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 18: Anti-anxiety Drugs (Drug Class) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Bipolar Disorder Market Share (in %) by Company: 2019 & 2025
Table 19: United States Bipolar Disorder Market Estimates and
Projections in US$ Million by Drug Class: 2018 to 2025
Table 20: Bipolar Disorder Market in the United States by Drug
Class: A Historic Review in US$ Million for 2009-2017
Table 21: United States Bipolar Disorder Market Share Breakdown
by Drug Class: 2009 VS 2019 VS 2025
JAPAN
Table 22: Japanese Market for Bipolar Disorder: Annual Sales
Estimates and Projections in US$ Million by Drug Class for the
Period 2018-2025
Table 23: Bipolar Disorder Market in Japan: Historic Sales
Analysis in US$ Million by Drug Class for the Period 2009-2017
Table 24: Japanese Bipolar Disorder Market Share Analysis by
Drug Class: 2009 VS 2019 VS 2025
CANADA
Table 25: Canadian Bipolar Disorder Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 26: Canadian Bipolar Disorder Historic Market Review by
Drug Class in US$ Million: 2009-2017
Table 27: Bipolar Disorder Market in Canada: Percentage Share
Breakdown of Sales by Drug Class for 2009, 2019, and 2025
CHINA
Table 28: Chinese Bipolar Disorder Market Growth Prospects in
US$ Million by Drug Class for the Period 2018-2025
Table 29: Bipolar Disorder Historic Market Analysis in China in
US$ Million by Drug Class: 2009-2017
Table 30: Chinese Bipolar Disorder Market by Drug Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
FRANCE
Table 31: Bipolar Disorder Market in France by Drug Class:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 32: French Bipolar Disorder Historic Market Scenario in
US$ Million by Drug Class: 2009-2017
Table 33: French Bipolar Disorder Market Share Analysis by Drug
Class: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Bipolar Disorder Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 34: European Bipolar Disorder Market Demand Scenario in
US$ Million by Region/Country: 2018-2025
Table 35: Bipolar Disorder Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2009-2017
Table 36: European Bipolar Disorder Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 37: European Bipolar Disorder Market Estimates and
Forecasts in US$ Million by Drug Class: 2018-2025
Table 38: Bipolar Disorder Market in Europe in US$ Million by
Drug Class: A Historic Review for the Period 2009-2017
Table 39: European Bipolar Disorder Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
ITALY
Table 40: Italian Bipolar Disorder Market Growth Prospects in
US$ Million by Drug Class for the Period 2018-2025
Table 41: Bipolar Disorder Historic Market Analysis in Italy in
US$ Million by Drug Class: 2009-2017
Table 42: Italian Bipolar Disorder Market by Drug Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
GERMANY
Table 43: Bipolar Disorder Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Drug Class for
the Period 2018-2025
Table 44: German Bipolar Disorder Historic Market Analysis in
US$ Million by Drug Class: 2009-2017
Table 45: German Bipolar Disorder Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
UNITED KINGDOM
Table 46: United Kingdom Market for Bipolar Disorder: Annual
Sales Estimates and Projections in US$ Million by Drug Class
for the Period 2018-2025
Table 47: Bipolar Disorder Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Drug Class for the
Period 2009-2017
Table 48: United Kingdom Bipolar Disorder Market Share Analysis
by Drug Class: 2009 VS 2019 VS 2025
SPAIN
Table 49: Spanish Bipolar Disorder Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 50: Spanish Bipolar Disorder Historic Market Review by
Drug Class in US$ Million: 2009-2017
Table 51: Bipolar Disorder Market in Spain: Percentage Share
Breakdown of Sales by Drug Class for 2009, 2019, and 2025
RUSSIA
Table 52: Russian Bipolar Disorder Market Estimates and
Projections in US$ Million by Drug Class: 2018 to 2025
Table 53: Bipolar Disorder Market in Russia by Drug Class: A
Historic Review in US$ Million for 2009-2017
Table 54: Russian Bipolar Disorder Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 55: Rest of Europe Bipolar Disorder Market Estimates and
Forecasts in US$ Million by Drug Class: 2018-2025
Table 56: Bipolar Disorder Market in Rest of Europe in US$
Million by Drug Class: A Historic Review for the Period
2009-2017
Table 57: Rest of Europe Bipolar Disorder Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 58: Asia-Pacific Bipolar Disorder Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 59: Bipolar Disorder Market in Asia-Pacific: Historic
Market Analysis in US$ Million by Region/Country for the Period
2009-2017
Table 60: Asia-Pacific Bipolar Disorder Market Share Analysis
by Region/Country: 2009 VS 2019 VS 2025
Table 61: Bipolar Disorder Market in Asia-Pacific by Drug
Class: Estimates and Projections in US$ Million for the Period
2018-2025
Table 62: Asia-Pacific Bipolar Disorder Historic Market
Scenario in US$ Million by Drug Class: 2009-2017
Table 63: Asia-Pacific Bipolar Disorder Market Share Analysis
by Drug Class: 2009 VS 2019 VS 2025
AUSTRALIA
Table 64: Bipolar Disorder Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Drug Class for
the Period 2018-2025
Table 65: Australian Bipolar Disorder Historic Market Analysis
in US$ Million by Drug Class: 2009-2017
Table 66: Australian Bipolar Disorder Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
INDIA
Table 67: Indian Bipolar Disorder Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 68: Indian Bipolar Disorder Historic Market Review by
Drug Class in US$ Million: 2009-2017
Table 69: Bipolar Disorder Market in India: Percentage Share
Breakdown of Sales by Drug Class for 2009, 2019, and 2025
SOUTH KOREA
Table 70: Bipolar Disorder Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Drug Class for
the Period 2018-2025
Table 71: South Korean Bipolar Disorder Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 72: Bipolar Disorder Market Share Distribution in South
Korea by Drug Class: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 73: Rest of Asia-Pacific Market for Bipolar Disorder:
Annual Sales Estimates and Projections in US$ Million by Drug
Class for the Period 2018-2025
Table 74: Bipolar Disorder Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Drug Class for the
Period 2009-2017
Table 75: Rest of Asia-Pacific Bipolar Disorder Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 76: Latin American Bipolar Disorder Market Trends by
Region/Country in US$ Million: 2018-2025
Table 77: Bipolar Disorder Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 78: Latin American Bipolar Disorder Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 79: Latin American Bipolar Disorder Market Growth
Prospects in US$ Million by Drug Class for the Period 2018-2025
Table 80: Bipolar Disorder Historic Market Analysis in Latin
America in US$ Million by Drug Class: 2009-2017
Table 81: Latin American Bipolar Disorder Market by Drug
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 82: Argentinean Bipolar Disorder Market Estimates and
Forecasts in US$ Million by Drug Class: 2018-2025
Table 83: Bipolar Disorder Market in Argentina in US$ Million
by Drug Class: A Historic Review for the Period 2009-2017
Table 84: Argentinean Bipolar Disorder Market Share Breakdown
by Drug Class: 2009 VS 2019 VS 2025
BRAZIL
Table 85: Bipolar Disorder Market in Brazil by Drug Class:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 86: Brazilian Bipolar Disorder Historic Market Scenario
in US$ Million by Drug Class: 2009-2017
Table 87: Brazilian Bipolar Disorder Market Share Analysis by
Drug Class: 2009 VS 2019 VS 2025
MEXICO
Table 88: Bipolar Disorder Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Drug Class for
the Period 2018-2025
Table 89: Mexican Bipolar Disorder Historic Market Analysis in
US$ Million by Drug Class: 2009-2017
Table 90: Mexican Bipolar Disorder Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 91: Rest of Latin America Bipolar Disorder Market
Estimates and Projections in US$ Million by Drug Class: 2018 to
2025
Table 92: Bipolar Disorder Market in Rest of Latin America by
Drug Class: A Historic Review in US$ Million for 2009-2017
Table 93: Rest of Latin America Bipolar Disorder Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 94: The Middle East Bipolar Disorder Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 95: Bipolar Disorder Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 96: The Middle East Bipolar Disorder Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 97: The Middle East Bipolar Disorder Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 98: The Middle East Bipolar Disorder Historic Market by
Drug Class in US$ Million: 2009-2017
Table 99: Bipolar Disorder Market in the Middle East:
Percentage Share Breakdown of Sales by Drug Class for 2009,
2019, and 2025
IRAN
Table 100: Iranian Market for Bipolar Disorder: Annual Sales
Estimates and Projections in US$ Million by Drug Class for the
Period 2018-2025
Table 101: Bipolar Disorder Market in Iran: Historic Sales
Analysis in US$ Million by Drug Class for the Period 2009-2017
Table 102: Iranian Bipolar Disorder Market Share Analysis by
Drug Class: 2009 VS 2019 VS 2025
ISRAEL
Table 103: Israeli Bipolar Disorder Market Estimates and
Forecasts in US$ Million by Drug Class: 2018-2025
Table 104: Bipolar Disorder Market in Israel in US$ Million by
Drug Class: A Historic Review for the Period 2009-2017
Table 105: Israeli Bipolar Disorder Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 106: Saudi Arabian Bipolar Disorder Market Growth
Prospects in US$ Million by Drug Class for the Period 2018-2025
Table 107: Bipolar Disorder Historic Market Analysis in Saudi
Arabia in US$ Million by Drug Class: 2009-2017
Table 108: Saudi Arabian Bipolar Disorder Market by Drug Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 109: Bipolar Disorder Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Million by Drug
Class for the Period 2018-2025
Table 110: United Arab Emirates Bipolar Disorder Historic
Market Analysis in US$ Million by Drug Class: 2009-2017
Table 111: Bipolar Disorder Market Share Distribution in United
Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 112: Bipolar Disorder Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by Drug
Class for the Period 2018-2025
Table 113: Rest of Middle East Bipolar Disorder Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 114: Rest of Middle East Bipolar Disorder Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
AFRICA
Table 115: African Bipolar Disorder Market Estimates and
Projections in US$ Million by Drug Class: 2018 to 2025
Table 116: Bipolar Disorder Market in Africa by Drug Class: A
Historic Review in US$ Million for 2009-2017
Table 117: African Bipolar Disorder Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBVIE
ALLERGAN PLC
ASTRAZENECA PLC
ELI LILLY AND COMPANY
GLAXOSMITHKLINE PLC
JANSSEN PHARMACEUTICA NV
NOVARTIS INTERNATIONAL AG
OTSUKA PHARMACEUTICAL
PFIZER

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817972/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.